ESPR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Esperion Therapeutics Inc

Watchlist Manager

Watchlist

Price: 3.13 USD Market Closed

Market Cap: $805.8m

	Esperion Therapeutics Inc NASDAQ:ESPR	US
	Davide Campari Milano NV MIL:CPR	IT
	Eupraxia Pharmaceuticals Inc NASDAQ:EPRX	CA
	FuSheng Precision Co Ltd TWSE:6670	TW
	CorVel Corp NASDAQ:CRVL	US
	Midwich Group PLC LSE:MIDW	UK
	Capitaland Investment Ltd OTC:CLILF	SG
	NeuPath Health Inc XTSX:NPTH	CA
	Leonardo SpA LSE:0ONG	IT

Profitability Summary

Esperion Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

68%

Strong 3Y Average Gross Margin

70%

Gross Margin is Increasing

61% > 68%

Healthy Operating Margin

15%

Negative 3Y Average Operating Margin

-47%

Operating Margin is Increasing

-229% > 15%

Negative Net Margin

-6%

Negative 3Y Average Net Margin

-81%

Net Margin is Increasing

-295% > -6%

Negative Free Cash Flow Margin

-3%

Negative 3Y Average Free Cash Flow Margin

-54%

Free Cash Flow Margin is Increasing

-235% > -3%

Low ROE

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-56%

ROIC is Increasing

-218% > 34%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.